These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24632665)

  • 21. Herculean appearance due to disseminated cysticercosis: case report.
    Kumar S; Jain S; Kashikar S
    Asian Pac J Trop Med; 2012 Dec; 5(12):1007-8. PubMed ID: 23199724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
    Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinsonism associated with neurocysticercosis.
    Sá DS; Teive HA; Troiano AR; Werneck LC
    Parkinsonism Relat Disord; 2005 Jan; 11(1):69-72. PubMed ID: 15619466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramedullary spinal cysticercosis cured with medical therapy: case report and review of literature.
    Chhiber SS; Singh B; Bansal P; Pandita KK; Razdan S; Singh J
    Surg Neurol; 2009 Dec; 72(6):765-8; discussion 768-9. PubMed ID: 19818478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocysticercosis-induced hemiballismus in a child.
    Karnik PS; Tullu MS; David JJ; Ghildiyal RG
    J Child Neurol; 2011 Jul; 26(7):904-6. PubMed ID: 21427444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocysticercosis in children: clinical characteristics and outcome.
    Talukdar B; Saxena A; Popli VK; Choudhury V
    Ann Trop Paediatr; 2002 Dec; 22(4):333-9. PubMed ID: 12530283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracranial hypertension secondary to neurocysticercosis].
    Vera de Pedro E; Vereas Martínez A; Pilar Orive J; López Fernández Y; Morteruel Arizkuren E
    An Pediatr (Barc); 2008 May; 68(5):530-2. PubMed ID: 18448006
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in computed tomogram in cerebral parenchymal cysticercosis treated with albendazole].
    Zhao S; Xu K
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):390-3. PubMed ID: 12563746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hydrocephalus secondary to neurocysticercosis.
    Weber D; Stevens EA; Couture DE; Winslow JE
    J Emerg Med; 2012 Aug; 43(2):342-3. PubMed ID: 20630680
    [No Abstract]   [Full Text] [Related]  

  • 30. Disseminated cysticercosis involving orbit, brain and subcutaneous tissue.
    Pushker N; Bajaj MS; Balasubramanya R
    J Infect; 2005 Dec; 51(5):e245-8. PubMed ID: 15904962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models.
    Montgomery MA; Ramos M; Kelvin EA; Carpio A; Jaramillo A; Hauser WA; Zhang H
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):781-788. PubMed ID: 31433058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.
    Chakravarty A
    Neurology; 2003 Jun; 60(11):1873-4; author reply 1874. PubMed ID: 14705604
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis.
    Cutter AC
    Neurology; 2003 Jun; 60(11):1873; author reply 1873-4. PubMed ID: 12796565
    [No Abstract]   [Full Text] [Related]  

  • 34. Concomitant steroid and albendazole for treating neurocysticercosis.
    Shahid SK; Singhi PD
    Indian Pediatr; 1999 Nov; 36(11):1176. PubMed ID: 10745352
    [No Abstract]   [Full Text] [Related]  

  • 35. A case from India of neurocysticercosis responsive to albendazole treatment.
    Zardi EM; Petrarca V; Pozio E; Uwechie V; Tamburrini A; Laghi V
    Parasite; 2000 Mar; 7(1):54-6. PubMed ID: 10743650
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurocysticercosis presenting as a 'Stroke Mimic'.
    Ghasemi R; Rowe A; Shah R; Venkatesan P; England TJ
    Acute Med; 2016; 15(2):79-83. PubMed ID: 27441309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Starry sky and beaded legs.
    Menon B
    Lancet Infect Dis; 2006 Mar; 6(3):183. PubMed ID: 16500600
    [No Abstract]   [Full Text] [Related]  

  • 38. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
    Göngora-Rivera F; Soto-Hernández JL; González Esquivel D; Cook HJ; Márquez-Caraveo C; Hernández Dávila R; Santos-Zambrano J
    Neurology; 2006 Feb; 66(3):436-8. PubMed ID: 16382035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Baird RA; Wiebe S; Zunt JR; Halperin JJ; Gronseth G; Roos KL
    Neurology; 2013 Apr; 80(15):1424-9. PubMed ID: 23568997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal cysticercosis: an unusual presentation.
    Chaurasia RN; Mishra VN; Jaiswal S
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25618884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.